Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical study validates new target for resistant tumors

June 6, 2012

PharmaGap provides update on lead program

June 6, 2012

Dr. Reddy's Laboratories enters worldwide biosimilars collaboration

June 6, 2012

MebioPharm set to launch phase II/III MBP-426 trial

June 6, 2012

Research alliance reached for carfilzomib and oprozomib

June 6, 2012

Novel candidate cancer therapies created at Aurigene Discovery Technologies

June 6, 2012

Clinical studies assess daily and twice-daily dosing of golvatinib

June 6, 2012

New phase I data disclosed on KX2-391 in chemotherapy-naive bone-metastatic CRPC

June 6, 2012

Astellas and Ambit begin phase IIb quizartinib monotherapy study in relapsed/refractory AML

June 5, 2012

First-in-human data presented on novel selective Notch pathway inhibitor

June 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...